Effect of acupuncture on post-stroke dysphagia: a randomized controlled trial

Lin Bai,Hongliang Cheng,Peijia Hu,Qingqing Wang,Zhang Shilin,Zhiqiang Shen,Fangyuan Xu,Xingxing Su,Yiting Zhang
DOI: https://doi.org/10.3389/fneur.2024.1391226
IF: 3.4
2024-06-21
Frontiers in Neurology
Abstract:Introduction: Post-stroke dysphagia (PSD) is associated with various complications that increase morbidity and mortality rates. Acupuncture has been used extensively in China to treat these complications; however, its therapeutic efficacy remains uncertain. We therefore aimed to study the clinical effects of acupuncture on PSD. Methods: Patients ( n = 101) were randomly divided into acupuncture ( n = 50) and rehabilitation training control ( n = 51) groups based on the treatment used. Both groups were treated once daily, 6 days a week, for a total of 4 weeks. Pulse oxygen saturation (SpO2) and standardized swallowing assessment (SSA) were performed before the intervention, 2 weeks into treatment, after the intervention (4 weeks post-intervention), and at a 6-month follow-up (28 weeks). The levels of hemoglobin (Hb) and albumin (ALB), and 5-hydroxytryptamine (5-HT) and dopamine (DA) were measured before the intervention, 2 weeks into treatment, and after the intervention (4 weeks), as nutrition and swallowing function indices, respectively. Results: Following the intervention, significant differences were observed between the acupuncture and control groups. The acupuncture group exhibited considerably superior enhancements in SpO2 and SSA scores at 4 weeks ( p < 0.001). Moreover, this group demonstrated significantly greater improvements in Hb, ALB, 5-HT, and DA values 4 weeks post-treatment ( p < 0.001). However, sex-based differences were not observed ( P > 0.005). Conclusion: Acupuncture treatment can improve the swallowing function and nutritional status of patients with PSD, and increase the levels of 5-HT and DA. These findings strongly support the efficacy of acupuncture as a therapeutic intervention in patients with PSD. Clinical trial registration: identifier, ChiCTR2100052201. (https://www.chictr.org.cn/).
neurosciences,clinical neurology
What problem does this paper attempt to address?